Results 181 to 190 of about 6,486,063 (267)

Front Matter Volume 14.2

open access: yesScottish Studies, 1970
[Editor]
doaj  

Slowing the curve: a single-arm meta-analysis of mFARS outcomes following omaveloxolone treatment in Friedreich ataxia. [PDF]

open access: yesBMJ Neurol Open
Ali A   +14 more
europepmc   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

open access: yesMolecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak   +10 more
wiley   +1 more source

Front Matter Volume 6.2

open access: yesScottish Studies, 1962
[Editor]
doaj  

Validation of automated image-guided programming in STN-DBS for Parkinson's disease. [PDF]

open access: yesFront Hum Neurosci
Umemura A   +5 more
europepmc   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Scottish Studies, Volume 5 (1961): Full Volume

open access: yesScottish Studies, 1961
[Editor]
doaj  

Development of a decision aid to help dually enrolled veterans make informed choices on medication sourcing. [PDF]

open access: yesJ Manag Care Spec Pharm
Hung A   +18 more
europepmc   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

Scottish Studies , Volume 4 (1960): Full Volume

open access: yesScottish Studies, 1960
[Editor]
doaj  

Home - About - Disclaimer - Privacy